Two top Egyptian young graduates selected to attend the global Novartis Biotechnology Leadership Camp “BioCamp” in Switzerland

Two top Egyptian young graduates selected to attend the global Novartis Biotechnology Leadership Camp “BioCamp” in Switzerland
2.5 5

Published August 17th, 2010 - 12:40 GMT

Rate Article:

 
PRINT Send Mail
comment (0)
Follow >
Click here to add Cairo as an alert
Cairo
,
Click here to add Cairo University as an alert
Cairo University
,
Click here to add German University in Cairo as an alert
German University in Cairo
,
Click here to add Manly Hospital as an alert
Manly Hospital
,
Click here to add Michael Copeman as an alert
Michael Copeman
,
Click here to add Novartis as an alert
Novartis
,
Click here to add Saher Hashem as an alert
Saher Hashem
,
Click here to add Salah El Sharkawy as an alert
Salah El Sharkawy

Three young Egyptian graduates have been chosen as best participants at the Novartis Biotechnology Leadership Camp "BioCamp" which was held from August 8-9, 2010 in Cairo, Egypt. The top two will travel to Switzerland to participate in the global BioCamp which will be held at the end of the month at Novartis headquarters while the third will act as an alternate in case any of the others cannot travel.

BioCamp is a pioneering two-day seminar that brings the biotechnology sector closer to 25 talented young men and women from different universities in Egypt who were selected following a rigorous application process.

The theme of this year's BioCamp was "Creating a paradigm shift in drug development".

The opening speech delivered by Dr. Salah El Sharkawy, Chief Scientific Officer and Vice President for Market Access & Government Relations at Novartis, stressed the role played by biotechnology in the future of the industry, focusing on drug development at Novartis.

The keynote address was delivered by Dr. Saher Hashem, Professor of Neurology, Cairo University, who gave an overview of hard to treat diseases such as Alzheimer's and Multiple Sclerois and explained how new medicines provide new hope for patients.

Delivering the second keynote address, was internationally renowned expert Dr. Michael Copeman, Medical Oncologist at Manly Hospital, Australia. Dr. Copeman spoke of the development of break-through drugs treating Chronic Myloid Leukemia. Following the lectures, the BioCamp participants split into five groups to work on a case study. On the second day of the seminar, each group got to present their plan to a panel of judges who then chose the best team and three top participants. The participants also had a chance to explore career opportunities and network with local and global leaders in the biotechnology sector. For many, this was the first of many networking events that will help place them firmly on the first steps of their careers.

The two winners who will participate in the global BioCamp in Switzerland are Farah Attaia, BA in Pharmacy & Biotechnology, German University in Cairo (GUC) and Lamiaa Bahnassawy, BA in Pharmacy & Biotechnology, GUC. 

Advertisement

Add a new comment

 avatar